Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Desireè Zambroni"'
Autor:
Michela Milani, Cesare Canepari, Simone Assanelli, Simone Merlin, Ester Borroni, Francesco Starinieri, Mauro Biffi, Fabio Russo, Anna Fabiano, Desirèe Zambroni, Andrea Annoni, Luigi Naldini, Antonia Follenzi, Alessio Cantore
Publikováno v:
EMBO Molecular Medicine, Vol 16, Iss 6, Pp 1427-1450 (2024)
Abstract Lentiviral vectors (LV) are efficient vehicles for in vivo gene delivery to the liver. LV integration into the chromatin of target cells ensures their transmission upon proliferation, thus allowing potentially life-long gene therapy followin
Externí odkaz:
https://doaj.org/article/b045f6dbf8624a8e8e0b19badc7c0b7b
Autor:
Federica Barbaglio, Daniela Belloni, Lydia Scarfò, Francesca Vittoria Sbrana, Maurilio Ponzoni, Lucia Bongiovanni, Luca Pavesi, Desiree Zambroni, Kostas Stamatopoulos, Valeria R. Caiolfa, Elisabetta Ferrero, Paolo Ghia, Cristina Scielzo
Publikováno v:
Haematologica, Vol 106, Iss 9 (2020)
Chronic Lymphocytic Leukemia (CLL) cells disseminate into supportive tissue microenvironments. To investigate the mechanisms involved in leukemic cell tissue retention we developed a 3D bone marrow (BM) microenvironment that recreates CLL - BM-stroma
Externí odkaz:
https://doaj.org/article/134d00127e4f4bf5a347218de2cb9b94
Autor:
Oronza A. Botrugno, Silvia Bianchessi, Desirée Zambroni, Michela Frenquelli, Daniela Belloni, Lucia Bongiovanni, Stefania Girlanda, Simona Di Terlizzi, Marina Ferrarini, Elisabetta Ferrero, Maurilio Ponzoni, Magda Marcatti, Giovanni Tonon
Publikováno v:
Haematologica, Vol 105, Iss 10 (2019)
Therapeutic strategies designed to tinker with cancer cell DNA damage response have led to the widespread use of PARP inhibitors for BRCA1/2-mutated cancers. In the haematological cancer multiple myeloma, we sought to identify analogous synthetic let
Externí odkaz:
https://doaj.org/article/b5da12f87772451a9ec1024dd4ad20bd
Autor:
Nicolò Musner, Mariapaola Sidoli, Desireè Zambroni, Ubaldo Del Carro, Daniela Ungaro, Maurizio D’Antonio, Maria L. Feltri, Lawrence Wrabetz
Publikováno v:
ASN Neuro, Vol 8 (2016)
In peripheral nerves, P0 glycoprotein accounts for more than 20% of myelin protein content. P0 is synthesized by Schwann cells, processed in the endoplasmic reticulum (ER) and enters the secretory pathway. However, the mutant P0 with S63 deleted (P0S
Externí odkaz:
https://doaj.org/article/41ac5c41bac942d0a056f189b16f606c